Differences in Phosphorylated Histone H2AX Foci Formation and Removal of Cells Exposed to Low and High Linear Energy Transfer Radiation
Journal:
Current Genomics
Volume:
13
Page:
418-425
Author(s):
Thomas Ernst Schmid, Olga. Zlobinskaya and Gabriele Multhoff
TGF-β in Epithelial to Mesenchymal Transition and Metastasis of Liver Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4135-4147
Author(s):
Patrick Reichl, Christine Haider, Markus Grubinger and Wolfgang Mikulits
Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials
Journal:
Current Angiogenesis (Discontinued)
Volume:
1
Page:
169-179
Author(s):
Benjamin Schmidt, Hae-June Lee, Sandra Ryeom and Sam S. Yoon
Targeting the Epidermal Growth Factor Receptor: Exploring the Potential of Novel Inhibitor N-(3-Ethynylphenyl)-6, 7-bis (2-methoxyethoxy) Quinolin- 4-Amine Using Docking and Molecular Dynamics Simulation
Journal:
Protein & Peptide Letters
Volume:
19
Page:
955-968
Author(s):
Shipra Gupta, Gauri Misra, Mohan Chandra Pant and Prahlad Kishore Seth
Clinical Trials in Chemoprevention of Head and Neck Cancers
Journal:
Reviews on Recent Clinical Trials
Volume:
7
Page:
249-254
Author(s):
Lining Feng and Zhi Wang
Non-aspirin Non-steroidal Anti-inflammatory Drugs for the Primary Chemoprevention of Non-gastrointestinal Cancer: Summary of Evidence
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4047-4070
Author(s):
Marcus Tolentino Silva, Tais Freire Galvao, Ivan Ricardo Zimmerman, Mauricio Gomes Pereira and Luciane Cruz Lopes
Synthetic Lethality to Overcome Cancer Drug Resistance
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3858-3873
Author(s):
L. Porcelli, A. E. Quatrale, P. Mantuano, N. Silvestris, A. E. Brunetti, H. Calvert, A. Paradiso and A. Azzariti
Role of PARP Inhibitors in Cancer Biology and Therapy
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3907-3921
Author(s):
D. Davar, J. H. Beumer, L. Hamieh and H. Tawbi
Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3922-3936
Author(s):
J. L. Illuzzi and D. M. Wilson III
Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3804-3811
Author(s):
Renee Vermeij, Ninke Leffers, Cornelis J. Melief, Toos Daemen and Hans W. Nijman